Giants tickets WeilMcLainPeerless Heater Co Westcast Inc

Giants tickets Plexvent owners Ultravent owners Valid claimsWill receive a new, Will receive a new, initiated on or professionally-installedprofessionally-installed before May 1, 2009, venting system free ofventing system for about with remediationcharge or a rebate up to$250 or a rebate of $250 completed and $400 towards purchase oftowards purchase of a requireda new, high-efficiencynew, high-efficiency documentation appliance from the same appliance from the same submitted bymanufacturer that doesmanufacturer that does October 1, 2009 not require HTPVnot require HTPV Valid claimsA rebate up to $400 A rebate up to $250 initiated after toward either an HTPV towardeither an HTPV May 1, 2009 replacement system, orreplacement system, or a a new, high-efficiencynew, high-efficiency appliance from the same appliance from the same manufacturer that doesmanufacturer that does not require HTPVnot require HTPVConsumers who register after May 1, 2009 and who choose to repair theirsystems will be responsible for up-front payment of parts, labor and permits,and will be responsible for arranging to have the work performed.Consumers should determine whether they have a recalled HTPV pipe system bychecking the vent pipes attached to their natural gas or propane furnace orboiler.Vent pipes subject to this recall can be identified as follows:the vent pipes are plastic;the vent pipes are colored gray or black;"Plexvent," "Plexvent II" or "Ultravent"is stamped on the vent pipe or printed on stickers placed on piecesusedto connect the vent pipes; andthe vent pipes are located on furnaces (and the pipes go through thesidewalls of structures) or on boilers.Other plastic vent pipes, such as white PVC, are not included in the recall.After checking the vent pipes, consumers should call (800) 758-3688 between 8a.m and 7 p.m. The following manufacturers are participating in this program:Armstrong Air Conditioning Inc Plexco Inc.Bard Manufacturing Co.Raypak Inc.Burnham Corp. Rheem Manufacturing Co.Dunkirk Radiator Corp.Slant/Fin Corp.Evcon Industries Inc. The Trane Co.Heat Controller Inc.Trianco-Heatmaker Inc.International Comfort Prod Utica Boilers Inc.

Corp.(USA)Lennox Industries Inc.Vaillant Corp.Nordyne Inc.Weil-McLainPeerless Heater Co Westcast Inc.Pennco Inc. York International Corp.CPSC reminds all consumers to have fuel-burning appliances professionallyinspected each year to check for cracks or separations in the vents that couldallow CO to leak into the home.In addition, CPSC recommends that every homeshould have at least one CO alarm.Manufacturers' Recall Hotline: (800) 758-3688CPSC Recall Hotline: (800) 638-2772CPSC Media Contact: (301) 504-7908SOURCEU.S. Consumer Product Safety CommissionCPSC Media Contact, 1-301-504-7908. New Service Provides Comprehensive Detection of Antiviral Resistant VirusStrains in Just Three Days, Helping Physicians Treat Patients Quickly, ImprovePatient Outcomes and Reduce Healthcare CostsKANSAS CITY, Mo.(Business Wire)ViraCor Laboratories, the leader in molecular diagnostic testing for infectiousdiseases, today announced the launch of a new cytomegalovirus (CMV) antiviralresistance test that provides diagnosis days faster than other tests on themarket. Developed in ViraCors laboratories, the molecular test accurately detects keygenetic mutations associated with antiviral resistance in CMV in three days orless Giants tickets.

CMV is a very common virus that, according to the Centers for Disease Control,infects up to 80 percent of adults in the United States by the age of 40. Because of the virus prevalence, immunocompromised patients are frequentlyprescribed antiviral therapies to prevent a likely CMV infection. "In patients with compromised immune systems, it is critical for doctors tostart the right CMV treatment quickly - before serious infection sets in," saidSteve Kleiboeker, Ph.D., Chief Scientific Officer of ViraCor Laboratories. "Whenwe created our CMV antiviral resistance testing service at ViraCor, we werecommitted to providing the fastest turnaround time possible. We start processingevery sample the day we receive it so that doctors can detect antiviralresistant strains of CMV in their patients within a few days, start the righttreatment and avoid complications from infection." CMV can lead to a number of medical complications for people with compromisedimmune systems including interstitial pneumonia, gastrointestinal infection,central nervous system disease, hepatitis, retinitis and encephalitis. In organtransplant patients, the virus has been associated with organ rejection anddysfunction, increased risk for bacterial or fungal opportunistic infections,and the development of Epstein-Barr Virus-associated post-transplantlymphoproliferative disease. Data has shown that, without antiviralintervention, symptomatic CMV infections occur in up to 50 percent ofkidney-pancreas transplant recipients, 41 percent of heart-lung transplantrecipients, 35 percent of heart transplant recipients, and 32 percent of kidneytransplant recipients.

Giants tickets ViraCors CMV Antiviral Resistance test detects keymutations associated with resistance by sequencing the CMV UL97phosphotransferase gene and the CMV UL54 DNA polymerase gene. As part of this new testing service,ViraCor provides scientific analysis and clinical interpretation of genemutations associated with antiviral resistance. "Laboratory testing is essential to diagnosing an antiviral resistant strain ofCMV, but, unfortunately, doctors usually have to wait up to two weeks to getresults. "At ViraCor, we are very pleased we can provide physicians theability to get accurate CMV antiviral resistance test results within three days.This unmatched turnaround time will give the doctors we serve the ability toprovide better care to their patients and, ultimately, save lives." ViraCor provides a range of novel infectious disease tests. In addition to CMV,the company offers tests for BK Virus (BKV), JC Virus (JCV), Epstein-Barr Virus(EBV), and enterovirus. For more information about ViraCors menu of tests,visit About ViraCor LaboratoriesViraCor Laboratories is a leading molecular diagnostic and research laboratorydedicated to providing innovative diagnostic testing to critical care patientsand those with compromised immune systems, with expertise in infectious diseasesand related pathogens, including viruses, protozoa and fungi. The company setthe standard for the diagnostic industry by turning all patient results aroundin less than 24 hours, unlike traditional lab results which can take three daysto several weeks.